Anna Gluskin

ANNA GLUSKIN is President and Chief Executive Officer of Generex
Biotechnology Corporation. She has held these senior positions
with Generex Biotechnology Corporation since the acquisition of
Generex Pharmaceuticals in 1998. Ms. Gluskin plans, coordinates
and manages Generex’s business activities, focusing especially on
new opportunities for applying Generex’s platform technology and
financing activities. Ms. Gluskin holds a Master’s degree in
Microbiology and Genetics from Moscow State University.